Sarepta Therapeutics (SRPT) Sees Intra-Day Selling Pressure

October 19, 2016 10:30 AM EDT

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

Sarepta Therapeutics (NASDAQ: SRPT) seeing notable intra-day pressure. Shares down 3.2%.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Trader Talk

Add Your Comment